CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 1 filers reported holding CHEMOCENTRYX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +109.1% | 2,681 | -0.4% | 0.00% | – |
| Q2 2022 | $66,000 | -23.3% | 2,693 | -21.4% | 0.00% | – |
| Q1 2022 | $86,000 | -24.6% | 3,425 | +9.3% | 0.00% | – |
| Q4 2021 | $114,000 | +115.1% | 3,134 | +1.7% | 0.00% | – |
| Q3 2021 | $53,000 | +103.8% | 3,083 | +57.1% | 0.00% | – |
| Q2 2021 | $26,000 | -91.8% | 1,962 | -68.4% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | -21.5% | 6,215 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $405,000 | +128.8% | 6,542 | +102.2% | 0.00% | – |
| Q3 2020 | $177,000 | – | 3,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |